Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Treasury Shares (2016 - 2024)

Corvus Pharmaceuticals' Treasury Shares history spans 7 years, with the latest figure at $400000.0 for Q3 2024.

  • Quarterly Treasury Shares changed N/A to $400000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $400000.0 through Sep 2024, changed N/A year-over-year, with the annual reading at $400000.0 for FY2023, N/A changed from the prior year.
  • Treasury Shares came in at $400000.0 for Q3 2024, roughly flat from $400000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $400000.0 in Q4 2023 to a low of $400000.0 in Q4 2023.